All bills
H.Con.Res. 81·110th Congress·House Concurrent Resolution

Expressing the sense of the Congress regarding bone marrow diseases.

Stage not supplied

The source supplies the latest action, but no lifecycle stage.

Latest action (7 Mar 2007): Referred to the Subcommittee on Health.

What this bill does

This resolution, H.Con.Res. 81, would express the sense of Congress regarding bone marrow diseases. It aims to encourage Americans to understand these diseases and their symptoms better, and to ensure that individuals diagnosed with them have access to various treatment and counseling options. The resolution also calls for families affected by these diseases to be connected with support networks and information services.

The bill specifically mentions aplastic anemia, myelodysplastic syndromes (MDS), and paroxysmal nocturnal hemoglobinuria (PNH), noting that these conditions affect individuals of all ages, genders, races, and ethnicities, with a higher incidence in those aged 60 and older. The resolution states that the Federal Government should work to raise awareness about early detection and treatment, fund research, and engage in public health initiatives related to these diseases.

H.Con.Res. 81 was introduced in the House of Representatives and referred to the Subcommittee on Health. As a concurrent resolution, it expresses the opinion of both the House and the Senate. Its passage would not create new laws or programs but would convey Congress's views on the importance of addressing bone marrow diseases.

Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.

Timeline

  1. 7 Mar 2007

    Referred to the Subcommittee on Health.

Common questions

What does H.Con.Res. 81 do?
This resolution, H.Con.Res. 81, would express the sense of Congress regarding bone marrow diseases. It aims to encourage Americans to understand these diseases and their symptoms better, and to ensure that individuals diagnosed with them have access to various treatment and counseling options. The resolution also calls for families affected by these diseases to be connected with support networks and information services. The bill specifically mentions aplastic anemia, myelodysplastic syndromes (MDS), and paroxysmal nocturnal hemoglobinuria (PNH), noting that these conditions affect individuals of all ages, genders, races, and ethnicities, with a higher incidence in those aged 60 and older. The resolution states that the Federal Government should work to raise awareness about early detection and treatment, fund research, and engage in public health initiatives related to these diseases. H.Con.Res. 81 was introduced in the House of Representatives and referred to the Subcommittee on Health. As a concurrent resolution, it expresses the opinion of both the House and the Senate. Its passage would not create new laws or programs but would convey Congress's views on the importance of addressing bone marrow diseases.
Has H.Con.Res. 81 become law?
The source does not supply a confirmed lifecycle stage for H.Con.Res. 81. Check the latest action and official source below.
Who sponsored H.Con.Res. 81?
H.Con.Res. 81 was sponsored by Rep. McGovern, James P. [D-MA-3] (D-MA), with 54 cosponsors.
What's the latest action on H.Con.Res. 81?
Referred to the Subcommittee on Health. (7 Mar 2007).

Related bills in Health

More bills from Rep. McGovern, James P. [D-MA-3]

Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.